Dr. Mikhail Blagosklonny and his Contributions to Medicine

Over the course of his career in medicine, Dr. Mikhail Blagosklonny has come a long way in his research. Dr. Mikhail Blagosklonny has been recognized on many occasions by his peers and by institutions. The fields of research for Dr. Mikhail Blagosklonny are anti-aging and oncology. Dr. Mikhail Blagosklonny has dedicated his career to the pursuit of a cure both for cancer and aging. During his research, Dr. Mikhail Blagosklonny has even found a bridge between the two subjects as he became an advocate for using a cancer treatment drug as a way to slow down the aging process as well. The drug is called Repamycin, and it employs TOR signaling. While views on the matter are of mixed nature, the concept has been gaining supporters over the past couple of years.

Dr. Mikhail Blagosklonny is a Russian scientist. He studied in Russia and then he moved to the United States of America to seek realization and embark upon his career of research. While in Russia, Dr. Mikhail Blagosklonny attended a renowned institution located in St. Petersburg. The city is the second largest in Russia, and it is also the home of many highly esteemed schools and higher academic establishments such as the First Pavlov State Medical University where Dr. Mikhail Blagosklonny had studied. Dr. Mikhail Blagosklonny graduated with a major in the field of Internal Science. He received a Ph. D. in oncology from the establishment as well as an M. D and to know more click here

Dr. Mikhail Blagosklonny took up a position in New York City. He worked as a teacher of internal medicine at the colleoverge of New York Medical College. After some years, Dr. Mikhail Blagosklonny received a promotion. He started occupying the position of professor of oncology at another institution – the Ordway Research Institute. Dr. Mikhail Blagosklonny did research there from 2002 up until 2009. In pursuit of a better place for research, Dr. Mikhail Blagosklonny moved on to his current place – the Roswell Park Cancer Institute is the one. Dr. Mikhail Blagosklonny has dedicated himself to conducting his research with very few limitations the since 2009. The Roswell Park Cancer Institute is one of the most advanced institutions in the fight against cancer in the United States of America.

While Dr. Mikhail Blagosklonny is hugely dedicated to his studies on oncology and biogerontology, he is also contributing through his works as an editor. Dr. Mikhail Blagosklonny is a part of the editing team of three medical journals, Cell Cycle, Aging, and Oncotarget as well. He has been working with some of his colleagues from the Roswell Park cancer institute. Dr. Mikhail Blagosklonny does not only do peer reviews and editing, but he has also done a great deal of writing. He has written and published about a hundred papers so far.

To know more click here

Leave a Reply

Your email address will not be published. Required fields are marked *